Suchergebnisse - "antibodies"

PubPharm (612.804)

41

Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months : a US retrospective claims study

enthalten in: Current medical research and opinion | 2024

von Varnado, O. | Vu, M. | Buysman, E. | +6

42

Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance

enthalten in: Journal of viral hepatitis | 2024

von Tully, D. | Power, K. | Sarette, J. | +8

UpdateOf: medRxiv. 2023 Jul 07;:. - PMID 37461565

43

Potential impact of unblinding on observed treatment effects in Alzheimer's disease trials

enthalten in: Alzheimer's & dementia : the journal of the Alzheimer's Association | 2024

von Wolters, F. | Labrecque, J.

44

Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies

enthalten in: The EMBO journal | 2024

von Bermejo-Jambrina, M. | van der Donk, L. | van Hamme, J. | +8

45

Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma : a prospective multicenter cohort study

enthalten in: International journal of clinical oncology | 2024

von Taoka, R. | Kamada, M. | Izumi, K. | +19

46

VCAM-1-targeted nanoparticles to diagnose, monitor and treat atherosclerosis

enthalten in: Nanomedicine (London, England) | 2024

von Castro, R. | Adair, J. | Mastro, A. | +2

47

Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccine

enthalten in: Revista clinica espanola | 2024

von Montagud, A. | Llenas-García, J. | Moragues, R. | +7

48

Development of a novel humanized anti-TSLP monoclonal antibody HZ-1127 with anti-allergic diseases and cancer potential

enthalten in: Antibody therapeutics | 2024

von Liu, X. | Han, J. | Wang, Q. | +7

49

Reforming solid tumor treatment : the emerging potential of smaller format antibody-drug conjugate

enthalten in: Antibody therapeutics | 2024

von Ma, X. | Wang, M. | Ying, T. | +1

50

Understanding the pharmacokinetic journey of Fc-fusion protein, rhIL-7-hyFc using complementary approach of two analytical methods, accelerator mass spectrometry and ELISA

enthalten in: Antibody therapeutics | 2024

von Kim, A. | Oh, M. | Lee, G. | +5